266
Participants
Start Date
April 30, 2012
Primary Completion Date
January 31, 2013
Study Completion Date
January 31, 2013
fostamatinib
fostamatinib 100 mg twice daily
placebo
placebo
Research Site, Huntsville
Research Site, Huntington Beach
Research Site, Santa Maria
Research Site, Trumbull
Research Site, Boca Raton
Research Site, Brandon
Research Site, Orlando
Research Site, Tampa
Research Site, Venice
Research Site, Decatur
Research Site, South Bend
Research Site, Cumberland
Research Site, Frederick
Research Site, Hagerstown
Research Site, Florissant
Research Site, Richmond Heights
Research Site, Freehold
Research Site, Albuquerque
Research Site, Brooklyn
Research Site, Charlotte
Research Site, Greensboro
Research Site, Lake Oswego
Research Site, Duncansville
Research Site, Memphis
Research Site, Austin
Research Site, Dallas
Research Site, Houston
Research Site, Lubbock
Research Site, Nassau Bay
Research Site, Tacoma
Research Site, Sevlievo
Research Site, Sofia
Research Site, Brno
Research Site, Hlučín
Research Site, Hostivice
Research Site, Kladno
Research Site, Ostrava-Trebovice
Research Site, Prague
Research Site, Aachen
Research Site, Halle
Research Site, Gdynia
Research Site, Grodzisk Mazowiecki
Research Site, Kalisz
Research Site, Katowice
Research Site, Lodz
Research Site, Poznan
Research Site, Środa Wielkopolska
Research Site, Wroclaw
Research Site, Bloemfontein
Research Site, Cape Town
Research Site, Durban
Research Site, Kempron Park
Research Site, Donetsk
Research Site, Kyiv
Research Site, Vinnytsia
Research Site, Zaporizhzhya
Lead Sponsor
AstraZeneca
INDUSTRY